DES and neoplasm: Given that ASPLT is defined by a certain immunophenotype - CD34 and desmin positivity with Rb protein loss - the absence of IHC data raises concerns about the reliability of these diagnoses and limits their value in refining our understanding of the tumor’s defining features.